Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.66% | 196.94 | 1.3% | $565.97m | |
| GILD | Gilead Sciences, Inc. | 0.70% | 66.42 | 0.9% | $368.71m | |
| BIIB | Biogen Inc. | 1.35% | 238.79 | 1.3% | $340.32m | |
| ILMN | Illumina, Inc. | 1.43% | 309.57 | 3.5% | $338.07m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.62% | 106.32 | 2.0% | $332.28m | |
| CELG | Celgene Corporation | 0.42% | 99.37 | 1.3% | $309.99m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.40% | 295.87 | 2.6% | $188.33m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.12% | 178.12 | 1.9% | $186.01m | |
| A | Agilent Technologies, Inc. | -0.18% | 77.93 | 1.6% | $185.14m | |
| EXAS | Exact Sciences Corporation | 0.55% | 103.97 | 24.1% | $152.91m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.34% | 82.51 | 14.6% | $139.60m | |
| ACAD | ACADIA Pharmaceuticals Inc. | -2.26% | 40.74 | 13.9% | $129.03m | |
| INCY | Incyte Corporation | 3.96% | 81.21 | 2.5% | $93.98m | |
| ALDR | Alder Biopharmaceuticals, Inc. | -0.11% | 18.64 | 10.2% | $81.98m | |
| BMRN | BioMarin Pharmaceutical Inc. | -1.38% | 74.95 | 4.3% | $76.08m |
Company Profile
PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.